Feredun Azari, M.D., general surgeon at Hospital of the University of Pennsylvania, Sardar Azari, and
Sunil Singhal, M.D., Penn Medicine physician and Director of the Center for Precision Surgery at the Abramson Cancer Center, invented an AI-powered optical tool for fluorescence-guided oncological surgery.
When a patient is diagnosed with cancer, fluorescence-guided surgery is often their best treatment option. This highly successful procedure uses an inert near-infrared dye to discern tumors from healthy cells. However, every potential tumor must be checked by an oncologist, a step which is both costly and time consuming.
To solve this problem, the inventors developed OptiDX, a smart camera powered by AI to evaluate tumor fluorescence in real time. This tool provides immediate and accurate tumor identification without the frozen section staining process normally required, saving over 30 minutes and thousands of dollars per tumor per operation.
PCI is actively seeking potential partners and investors for further development of this exciting technology opportunity. You can find more information about the technology here.
